Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > January 9th warrants

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jan 06, 2023 11:39am

224 Views

Post# 35206996

RE:RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrants

Yes the extension is the fair thing to do for those that took part in those PP's, for sure because of covid and to a lesser extent the 12 under treated patients pushing the timelines out.

And it won't mean a thing when this thing pops, that volume would be taken care of in one day most likely.

The excitement sure is building.

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army